ArticlePharmacoEconomics2025

Cost-Utility Analysis of Treatment Sequences for Moderate-to-Severe Crohn's Disease.

Matthijs M Versteegh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.